NCT02025374View on ClinicalTrials.gov

Hyperbaric Bupivacaine and Hyperbaric Levobupivacaine in C/S

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2016

Conditions
Health CareDrugs
Interventions
DRUG

Hyperbaric levobupivacaine

DRUG

Hyperbaric bupivacaine % 0.5

Trial Locations (1)

10145

Balıkesir University Faculty of Medicine, Balıkesir

All Listed Sponsors
lead

Balikesir University

OTHER

NCT02025374 - Hyperbaric Bupivacaine and Hyperbaric Levobupivacaine in C/S | Biotech Hunter | Biotech Hunter